Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders. - Erskine D; Taylor JP; Bakker G; Brown AJH; Tasker T; Nathan PJ (Drug discovery today, 2019)